Form 4: Kenvue CPO Luani Alvarado Granted 79,407 RSUs

Kenvue's Chief People Officer, Luani Alvarado, was granted 79,407 Restricted Stock Units, vesting over three years.

Summary

• Luani Alvarado, Chief People Officer of Kenvue Inc. (KVUE), was granted 79,407 Restricted Stock Units (RSUs).
• The transaction date for this grant was March 2, 2026.
• Each RSU corresponds one-for-one with Kenvue's common stock.
• The award vests in three equal installments on March 2, 2027, March 2, 2028, and March 2, 2029.
• Vesting is contingent upon Luani Alvarado's continued service through each specified vesting date.
• Following this transaction, Luani Alvarado beneficially owns 79,407 derivative securities (RSUs).

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive signal, reflecting Kenvue's commitment to executive retention and aligning management incentives with long-term shareholder value, which is a standard and healthy corporate governance practice.

Positives

• The grant of Restricted Stock Units to a key executive like the Chief People Officer indicates a commitment to retaining top talent.
• Aligns the executive's long-term interests with those of shareholders through equity ownership.
• The vesting schedule incentivizes continued service and performance over a multi-year period.

Negatives

• The RSUs are subject to a multi-year vesting schedule, meaning the executive does not have immediate full ownership or liquidity.
• The value of the award is tied to the future performance of Kenvue's common stock, introducing market risk.

Risks

• The vesting of the Restricted Stock Units is subject to the reporting person's continued service through the specified vesting dates.
• The value of the RSUs upon vesting is dependent on Kenvue's common stock price at that time, exposing the holder to market fluctuations.

Future Outlook

The grant of long-term equity compensation suggests Kenvue's strategy to retain key executives and align their incentives with the company's long-term performance and shareholder value creation.

Management Comments

• These units correspond 1 for 1 with the Company's common stock.
• This award vests in three equal installments on 03/02/2027, 03/02/2028, and 03/02/2029, subject to the reporting person's continued service through such vesting date.

Industry Context

StockSavvy.ai notes that granting Restricted Stock Units (RSUs) is a standard practice in executive compensation across various industries, particularly in consumer health and pharmaceutical sectors where long-term retention of leadership is crucial for strategic execution and product development cycles. This aligns Kenvue with common industry practices for incentivizing and retaining senior management.

Comparison to Industry Standards

• The grant of RSUs as a form of executive compensation is a widely adopted practice, comparable to compensation structures at companies like Procter & Gamble (PG), Johnson & Johnson (JNJ), and Unilever (UL), which frequently use equity awards to align executive interests with long-term shareholder value.
• The three-year vesting schedule with equal annual installments is a common structure designed to encourage executive retention and sustained performance, consistent with benchmarks in the consumer goods and healthcare industries.

Corporate Governance

Stakeholder Impact

• Shareholders: Benefits from increased alignment of executive interests with long-term company performance and retention of key talent.
• Employees: May signal stability in leadership and a commitment to competitive compensation practices for senior roles.

Next Steps

• First vesting of 26,469 RSUs on March 2, 2027.
• Second vesting of 26,469 RSUs on March 2, 2028.
• Third vesting of 26,469 RSUs on March 2, 2029.

Key Dates

Keywords

Kenvue, KVUE, Luani Alvarado, Chief People Officer, Restricted Stock Units, RSU, insider transaction, executive compensation, equity grant, Form 4